13 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
PRESSURE DISPLAY BOX,DLP DISPOSABLE PRESSURE DISPLAY SETS-NON STERILE VERSIONS
FDA 510(k)
FDA Class 2
·Cardiovascular
CapSure® Spine System
FDA UDI
Spine Wave, Inc.·10840642104387·Rod Straight 5.5 x 35mm
DANmed
FDA UDI
DANNORITZER Medizintechnik GmbH & Co. KG·04251351101724·LAP-Instrument, Ø5mm, l=350mm, flushp.
Forcep...
Recon
FDA UDI
Revelation Medical Devices·G318101132350·Curved Osteotome
SMR CEMENTL. REV. STEM Ø13 MM
FDA Adverse Event
Injury
·LIMACORPORATE S.P.A.·Product code KWS·November 12, 2018
ACCU-CHEK COMFORT CURVE
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS·Product code CFR·August 12, 2006
ERBEFLO 2 DISPOSABLE TUBING SYSTEM
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
MODIFICATION TO SYNCHRON CONTROL
FDA 510(k)
FDA Class 1
·Clinical Chemistry
9800
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·May 8, 2013
FRESENIUS 2008K
FDA Adverse Event
Death
·FRESENIUS MEDICAL CARE NORTH AMERICA·Product code KDI·September 2, 2014
TENSION FREE VAGINAL TAPE
FDA Adverse Event
Injury
·ETHICON·Product code FTL·June 3, 2011
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012
INLIVEN CRT-P, Model Numbers: a) V284 b) V285 c) W274 d) W275 (added 7/15/2021)
FDA Enforcement
Class I
·Ongoing·Boston Scientific Corporation·July 21, 2021